WCN24-901 EFFECT OF FGF23 AND PARICALCITOL TREATMEMT IN YOUNG HEMODIALYSIS PATIENTS WITH DIASTOLIC DYSFUNCTION

WCN24-901 EFFECT OF FGF23 AND PARICALCITOL TREATMEMT IN YOUNG HEMODIALYSIS PATIENTS WITH DIASTOLIC DYSFUNCTION

Saved in:

Bibliographic Details
Main Authors:	Wacharee Seeherunvong, Chryso Katsoufis, Marissa DeFreitas, Sethuraman Swaminathan, Jayanthi Chandar, Carolyn Abitbol, Michael Freundlich
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S246802492400127X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-689 PREVALENCE AND RENAL OUTCOMES OF NEPHROMEGALY IN CHILDREN WITH BILIARY ATRESIA BEFORE AND AFTER LIVER TRANSPLANTATION
by: Marissa Defreitas, et al.
Published: (2024-04-01)

Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
by: Tara B. Gavcovich, et al.
Published: (2025-03-01)

FGF23 Producing Mesenchymal Tumor
by: Lucyna Papierska, et al.
Published: (2014-01-01)

Case series of kidney transplantation in two pediatric recipients with rare genetic diseases and intellectual disability
by: Marina Mata, et al.
Published: (2024-12-01)

Clinical Significance of FGF-23 in Patients with CKD
by: Domenico Russo, et al.
Published: (2011-01-01)

Tumor-Induced Osteomalacia in a Patient With FGF23-Amplified Lung Adenocarcinoma and FGF23-Deleted SCLC: Case Report
by: Marcello Moro Queiroz, MD, et al.
Published: (2025-06-01)

Immunity Against <i>Mycobacterium avium</i> Induced by DAR-901 and BCG
by: Getahun Abate, et al.
Published: (2025-06-01)

Paricalcitol-loaded PLGA nanodrug for the amelioration of sepsis-associated acute kidney injury
by: Zhi Li, et al.
Published: (2025-06-01)

Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease
by: Hilla Chen, et al.
Published: (2025-03-01)

Reparative effects of paricalcitol and calcitriol in patients with cardiorenal syndrome and chronic allograft nephropathy
by: A. N. Kharlamov, et al.
Published: (1970-01-01)

Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasis.
by: Min Young Park, et al.
Published: (2024-01-01)

WCN25-901 CLINICAL AND GENETIC CHARACTERISTICS CHILDREN WITH PROTEINURIA ASSOCIATED WITH CUBN VARIANTS
by: Larisa Prikhodina, et al.
Published: (2025-02-01)

Effect of different doses of paricalcitol on the expression of vitamin D receptors in mice liver tissue
by: T. P. Sataieva, et al.
Published: (2023-09-01)

Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl
by: Christina Bothou, et al.
Published: (2018-01-01)

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor
by: A. S. Pushkareva, et al.
Published: (2022-05-01)

Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.
by: Despina Sitara, et al.
Published: (2008-08-01)

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
by: S. S. Rodionova, et al.
Published: (2019-12-01)

Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway
by: Jiawei Zhang, et al.
Published: (2025-04-01)

Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.
by: Isabelle Six, et al.
Published: (2014-01-01)

Molecular Mechanisms Underlying Accelerated Aging by Defects in the FGF23-Klotho System
by: Makoto Kuro-o
Published: (2018-01-01)

The transcription factor BBX regulates phosphate homeostasis through the modulation of FGF23
by: Su Jeong Lee, et al.
Published: (2024-11-01)

Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.
by: Neil Charles Wallace Mackenzie, et al.
Published: (2012-01-01)

FGF-23 as a Biomarker for Carotid Plaque Vulnerability: A Systematic Review
by: Joana Oliveira-Sousa, et al.
Published: (2025-03-01)

Corrigendum: Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway
by: Jiawei Zhang, et al.
Published: (2025-06-01)

The Roxadustat (FG-4592) ameliorates tubulointerstitial fibrosis by promoting intact FGF23 cleavage
by: Jing Wang, et al.
Published: (2025-04-01)

The Effect of Ferric Carboxymaltose on Fibroblast Growth Factor 23 (FGF23) in Children with Iron Deficiency Anemia Due to Gastrointestinal Diseases
by: Maria Ntoumpara, et al.
Published: (2024-11-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01)

Correlation linking fibroblast growth factor 23 in circulation (FGF-23) and serum aldosterone levels in different stages of chronic kidney disease
by: Amira Hassan Elsaid Dohuim, et al.
Published: (2025-03-01)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
by: Katarzyna Muras-Szwedziak, et al.
Published: (2023-12-01)

Serum FGF-23 and Vitamin D Deficiency as Predictors of Metabolic Syndrome in Chronic Kidney Disease
by: Tazeen Shah, et al.
Published: (2025-04-01)

Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
by: Sathish K Murali, et al.
Published: (2016-04-01)

Cardiovascular Risk Factors and Chronic Kidney Disease—FGF23: A Key Molecule in the Cardiovascular Disease
by: Rika Jimbo, et al.
Published: (2014-01-01)

Clinical value of serum iPTH, ALP and serum markers levels in patients with secondary hyperparathyroidism receiving paricalcitol combined with cinacalcet
by: Ruifang Song, et al.
Published: (2025-01-01)

Circulating FGF-23 Is Associated With Increased Risk of Osteoporosis and Fractures in Hemodialysis Patients: A Prospective Observational Study
by: Dong Liu, et al.
Published: (2024-01-01)

Hypoxia Activates FGF-23-ERK/MAPK Signaling Pathway in Ischemia-Reperfusion-Induced Acute Kidney Injury
by: Weihua Liu, et al.
Published: (2024-10-01)

FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness.
by: Gemma Llauradó, et al.
Published: (2015-01-01)

Associations between endogenous sex hormones and FGF-23 among women and men in the Multi-Ethnic Study of Atherosclerosis.
by: Oluseye Ogunmoroti, et al.
Published: (2022-01-01)

Exploring patterns of online sexual experiences and associated factors in 7,901 high school students in Hong Kong: A latent class analysis
by: Ted C.T. Fong, et al.
Published: (2025-03-01)

Expression of FGF23 and α-KLOTHO in Normal Human Kidney Development and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
by: Patricija Bajt, et al.
Published: (2025-06-01)

Use of burosumab in McCune Albright syndrome: case report and review of literature in mosaic disorders with FGF23 overproduction
by: Alessandro Barbato, et al.
Published: (2025-05-01)